Biosion
Dr. Karin has spent his academic career investigating stress and inflammation signaling, covering the entire gamut of experimental approaches from biochemistry and molecular cell biology to animal pathophysiology. Discovering how infection, inflammation, radiation, or environmental stressors activate AP-1, NF-κB and other transcription factors, he investigated how these findings apply to the pathogenesis of cancer, degenerative and metabolic diseases.
This person is not in the org chart
This person is not in any offices
Biosion
Biosion is a leading “In Global For Global” clinical stage biotechnology company developing innovative biologics to address resistant, relapsed and residual disease for patients worldwide.